Secukinumab Provides Sustained Improvements in Clinical and Imaging Outcomes in Patients with Psoriatic Arthritis and Axial Manifestations: Results from the MAXIMISE Trial

被引：0
|
作者：
Baraliakos, Xenofon [1 ]
Gossec, Laure [2 ,3 ]
Pournara, Effie [4 ]
Jeka, Slawomir [5 ]
Blanco, Ricardo [6 ]
D'Angelo, Salvatore [7 ]
Schett, Georg [8 ]
Schulz, Barbara [4 ]
Rissler, Michael [4 ]
Whyms, Dermot [9 ]
Perella, Chiara [4 ]
Coates, Laura [10 ]
机构：
[1] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Bochum, Germany
[2] Sorbonne Univ, Paris, France
[3] Hop Univ Pitie Salpetriere, Paris, France
[4] Novartis Pharma AG, Basel, Switzerland
[5] CM UMK, Univ Hosp 2, Bydgoszcz, Poland
[6] Hosp Univ Marques Valdecilla, Santander, Cantabria, Spain
[7] San Carlo Hosp Potenza, Dept Rheumatol, Lucania & Rheumatol Inst Lucania IRel, Potenza, Italy
[8] Friedrich Alexander Univ Erlangen Nuremberg, Erlangen, Germany
[9] Novartis Ireland Ltd, Dublin, Ireland
[10] Univ Oxford, Oxford, England
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0505
引用
收藏
页数：3
相关论文
共 50 条
  • [41] PATIENT CLUSTERS IDENTIFIED BY MACHINE LEARNING FROM A POOLED ANALYSIS OF THE CLINICAL DEVELOPMENT PROGRAM OF SECUKINUMAB IN PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS, AND PSORIATIC ARTHRITIS WITH AXIAL MANIFESTATIONS
    Baraliakos, Xenofon
    Pournara, Effie
    Gladman, Dafna D.
    Mease, Philip J.
    Ostor, Andrew
    Jahandideh, Samad
    Coates, Laura
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 40 - 40
  • [42] Patient Clusters Identified by Machine Learning from a Pooled Analysis of the Clinical Development Program of Secukinumab in Psoriatic Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis with Axial Manifestations
    Baraliakos, Xenofon
    Pournara, Effie
    Gladman, Dafna
    Mease, Philip J.
    Jahandideh, Samad S.
    Coates, Laura
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2985 - 2987
  • [43] Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study
    McInnes, Iain B.
    Mease, Philip J.
    Schett, Georg
    Kirkham, Bruce
    Strand, Vibeke
    Williams, Nicole
    Fox, Todd
    Pricop, Luminita
    Jugl, Steffen M.
    Gandhi, Kunal K.
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [44] SECUKINUMAB PROVIDES RAPID AND SUSTAINED PAIN RELIEF IN PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM THE FUTURE 2 STUDY
    McInnes, I. B.
    Mease, P. J.
    Schett, G.
    Kirkham, B.
    Strand, V.
    Williams, N.
    Fox, T.
    Pricop, L.
    Jugl, S.
    Gandhi, K. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 675 - 675
  • [45] Secukinumab provides rapid and sustained reductions in dactylitis, enthesitis, and nail psoriasis in patients with psoriatic arthritis (PsA)
    Nash, P.
    McInnes, I. B.
    Kirkham, B.
    Mease, P.
    Bhosekar, V.
    Mpofu, S.
    Gandhi, K.
    Gaillez, C.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 74 - 74
  • [46] Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study
    Iain B. McInnes
    Philip J. Mease
    Georg Schett
    Bruce Kirkham
    Vibeke Strand
    Nicole Williams
    Todd Fox
    Luminita Pricop
    Steffen M. Jugl
    Kunal K. Gandhi
    Arthritis Research & Therapy, 20
  • [47] RESPONSIVENESS OF ULTRASOUND SYNOVITIS AND CLINICAL OUTCOMES IN PSORIATIC ARTHRITIS TREATED WITH SECUKINUMAB: DATA FROM THE ULTIMATE TRIAL
    Boers, M.
    Conaghan, P. G.
    Schett, G.
    Mandl, P.
    Naredo, E.
    Van den Bosch, F.
    Burgos-Vargas, R.
    Duggan, A. M.
    Goyanka, P.
    Gaillez, C.
    D'agostino, M. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 314 - 314
  • [48] SUBCUTANEOUS SECUKINUMAB PROVIDES SUSTAINED INHIBITION OF RADIOGRAPHIC PROGRESSION IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 52-WEEK RESULTS FROM A PHASE 3 STUDY
    Mease, Philip
    van der Heijde, Desiree
    Landewe, Robert
    Mpofu, Shephard
    Rahman, Proton
    Tahir, Hasan
    Singhal, Atul
    Boettcher, Elke
    Navarra, Sandra
    Zhu, Xuan
    Readie, Aimee
    Abrams, Ken
    Pricop, Luminita
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S10 - S10
  • [49] Subcutaneous Secukinumab Provides Sustained Inhibition of Radiographic Progression in Patients with Active Psoriatic Arthritis: 52-Week Results from a Phase 3 Study
    Mease, Philip J.
    van der Heijde, Desiree
    Landewe, Robert B. M.
    Mpofu, Shephard
    Rahman, Proton
    Tahir, Hasan
    Singhal, Atul
    Bottcher, Elke
    Navarra, Sandra V.
    Zhu, Xuan
    Readie, Aimee
    Pricop, Luminita
    Abrams, Ken
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [50] Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis - Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)
    Antoni, CE
    Kavanagh, A
    Kirkham, B
    Tutuncu, Z
    Burmester, GR
    Schneider, U
    Furst, DE
    Molitor, J
    Keystone, E
    Gladman, D
    Manger, B
    Wassenberg, S
    Weier, R
    Wallace, DJ
    Weisman, MH
    Kalden, JR
    Smolen, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (04): : 1227 - 1236
12345